DealShot: China’s Sinobioway Sunterra Biotechnology Invests $10M In US Adoptive Cellular Therapy Firm F1 Oncology

Follow Us:

China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis.

Here you can find out where Chinese investors have been investing their money in at around 5pm each workday.

CompanyRoundAmountLead InvestorParticipantsCompany Intro
XinshangSeries CUS$50 millionGGV Capital, Joy CapitalNorthern Light Venture CapitalXinshang is a Chinese customer to customer(C2C) marketplace for secondhand luxury goods, including bags, shoes, watches, clothes and jewelries.
Peilian.comSeries BHundreds of millions of RMBTencent Holdings, Orchid Asia GroupBlueRun Ventures, GSR Ventures, Long is a Shanghai-based online music tutoring platform. Tutors can observe how students play music via digital cameras and video chat and provide immediate feedback, verbally or in writing.
MoSeekerSeries BUS$15 millionundisclosedRecruit HoldingsMoSeeker is a Chinese recruitment solution provider. Its smartphone app can help HR synchronously post new jobs on various online platforms and provide real-time data analysis to better understand the talent market.
UlucuSeries CUS$12 millionChina Merchants CapitalZhongchanng Data, Shanghai Milestone Asset Management Co., Ltd, Shanghai Momoying Investment Development Center (LP)Ulucu is a Shanghai-based network monitoring technology company. Based on face recognition, video analysis, speech processing and other AI technologies, the company provides security monitoring, consumer analysis, personnel management, cash flow management and product layout solutions for Chinese innovative retail stores.
HuangjinguanjiaSeries BTens of millions of RMBMarathon Venture PartnersBlueRun Ventures, Qihoo 360Huangjinguanjia, which means gold keeper in Chinese and operates under, is a Chinese online financial service platform focusing on gold trading and investment.
HuiyihuiyingSeries CundisclosedCDH InvestmentsHuiyihuiying is a Beijing-based medical imaging technology start-up. It operates artificial intelligence-based medical imaging diagnosis platform and big data analysis cloud platform. Its products can help diagnose lung cancer, breast cancer, colon cancer, ovarian cancer and other common cancers.
Hongliyu CinemaSeries BUS$15 millionLegend CapitalShenzhen Guangliang Qixin Fund, Guangwo CapitalHongliyu Cinema is a Chinese rural cinema operator. Its business scope includes cinema investment and construction, development cooperation, operation management, as well as film production, and advertising, etc.
MoredianSeries ATens of millions of RMBAlibaba GroupZJU Joint Innovation InvestmentMoredian is a Hangzhou-based face recognition technology and application provider. Its products include cloud-based visitor system, access control system, attendance system, and many other smart hardware.
Panda InsuranceSeries A+US$7.7 millionYonyou, Legend Star, QF Capital, Neovision Capital, Origins Capital, Hangzhou Win-Light Investment Co., LtdPanda Insurance is a Beijing-based automobile insurance sales management platform. Its parent company is Beijing Etop Pass Technology Co., Ltd.
F1 OncologyPrivate placementUS$10 millionShanghai Sinobioway Sunterra BiotechnologyF1 Oncology is a U.S.-based biotechnology company discovering and developing adoptive cellular therapies for solid tumors.

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *